LAVA Therapeutics
Why Robinhood?
You can watch LVTX and buy or sell other stocks, ETFs, and their options commission-free!About LVTX
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
LVTX Key Statistics
Stock Snapshot
LAVA Therapeutics(LVTX) stock is priced at $1.74, giving the company a market capitalization of 45.77M. It carries a P/E multiple of -2.02.
On 2026-04-04, LAVA Therapeutics(LVTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 138.76K.
The stock's 52-week range extends from a low of $0.85 to a high of $2.00.
The stock's 52-week range extends from a low of $0.85 to a high of $2.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.